CRP and early-onset autosomal dominant Alzheimer disease: We chose to perform a TWAS of CRP in 361,194 UK Biobank subjects, as CRP is a biomarker of chronic low-grade inflammation, with elevated CRP levels associated with a broad array of complex diseases, including cardiovascular disease, Alzheimer’s disease, and schizophrenia25.